Calvin Sandra

CIK 00018829091 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001882909

Recent Transactions

50 trades

Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-15$62.85/sh−800→ 42,653 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-15$27.50/sh+2,500→ 44,853 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-15$22.40/sh+1,250→ 46,103 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-15$20.46/sh+1,625→ 47,728 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-15$62.13/sh−4,275→ 43,453 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-09-15−1,625→ 17,875 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-09-15−1,250→ 3,750 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-09-15−2,500→ 0 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-09-15$63.66/sh−300→ 42,353 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$22.40/sh+2,500→ 51,580 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-04-14−6,250→ 12,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-04-14−2,500→ 5,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$41.07/sh−21,977→ 42,353 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$20.46/sh+6,500→ 64,330 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$8.93/sh+6,250→ 57,830 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-04-14−6,500→ 19,500 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-02-03$32.12/sh−4,333→ 49,080 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-01-31+15,180→ 53,413 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-01-31+20,160→ 20,160 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-12-24$40.00/sh−7,402→ 38,233 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-12-15$36.00/sh−2,910→ 45,635 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$36.00/sh−67,115→ 48,545 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-11-04−6,250→ 18,750 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-11-04−12,500→ 7,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-11-04−15,000→ 2,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-11-04−17,500→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$25.25/sh+10,000→ 64,410 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$26.88/sh+17,500→ 81,910 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$27.50/sh+15,000→ 96,910 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$22.40/sh+12,500→ 109,410 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$8.93/sh+6,250→ 115,660 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-11-04−10,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-02-11−10,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$16.23/sh+10,000→ 73,654 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$25.00/sh−10,000→ 63,654 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$17.44/sh+10,000→ 73,654 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$25.00/sh−10,000→ 63,654 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$17.96/sh+10,000→ 73,654 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$25.00/sh−10,000→ 63,654 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$15.46/sh+15,000→ 78,654 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$25.00/sh−15,000→ 63,654 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$25.00/sh−9,244→ 54,410 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-02-11−10,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-02-11−10,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-02-11−15,000→ 0 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-03$20.12/sh−3,348→ 63,654 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-31+13,000→ 67,002 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-01-31+26,000→ 26,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-22$18.94/sh−925→ 54,002 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-12-26$17.22/sh−15,000→ 54,927 total

Companies

Travere Therapeutics, Inc.
SVP, CHIEF ACCOUNTING OFFICER
$TVTX

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DRIVE, SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov